Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-117,076
Closed -$2.34M 973
2022
Q1
$2.34M Buy
+117,076
New +$2.03M 0.66% 24
2021
Q4
Sell
-214,172
Closed -$2.99M 1025
2021
Q3
$2.99M Buy
214,172
+2,716
+1% +$53.3K 0.72% 25
2021
Q2
$4.74M Sell
211,456
-95,285
-31% -$1.99M 1.07% 14
2021
Q1
$5.33M Buy
306,741
+127,311
+71% +$2.22M 1.52% 9
2020
Q4
$3.01M Buy
+179,430
New +$2.39M 0.88% 25
2020
Q1
Sell
-59,129
Closed -$784K 740
2019
Q4
$784K Sell
59,129
-71,305
-55% -$857K 0.15% 118
2019
Q3
$1.5M Buy
130,434
+82,300
+171% +$998K 0.27% 83
2019
Q2
$647K Buy
48,134
+17,203
+56% +$221K 0.11% 142
2019
Q1
$404K Buy
+30,931
New +$400K 0.08% 166
2018
Q2
Sell
-3,522
Closed -$42.2K 704
2018
Q1
$42.2K Sell
3,522
-104,350
-97% -$1.37M 0.01% 361
2017
Q4
$1.32M Buy
107,872
+19,691
+22% +$209K 0.23% 80
2017
Q3
$888K Buy
88,181
+4,211
+5% +$42.4K 0.17% 90
2017
Q2
$735K Sell
83,970
-1,069,434
-93% -$9.09M 0.16% 103
2017
Q1
$11M Buy
+1,153,404
New +$11.5M 2.48% 6
2016
Q4
Sell
-1,561,602
Closed -$8.59M 684
2016
Q3
$8.59M Sell
1,561,602
-435,764
-22% -$2.39M 1.29% 13
2016
Q2
$10.1M Buy
1,997,366
+1,695,132
+561% +$7.93M 1.67% 30
2016
Q1
$1.27M Buy
+302,234
New +$939K 0.17% 79
2015
Q4
Sell
-52,504
Closed -$221K 567
2015
Q3
$221K Buy
+52,504
New +$268K 0.03% 179
2015
Q2
Sell
-553,263
Closed -$3.7M 558
2015
Q1
$3.13M Buy
+553,263
New +$4.01M 0.34% 52

Other funds holding VALE

Exane Derivatives's VALE Position: Q2 2022 in Review

Exane Derivatives sold out of Vale (VALE) in Q2 2022, closing a stake of 117,076 shares — an estimated $2.34M sold.

Exane Derivatives first reported a position in VALE in Q1 2015 and held it in 19 quarters. The position peaked at $11M in Q1 2017. 485 funds tracked by Wall St. Rank hold VALE as of Q2 2022.

  • Exane Derivatives reported no remaining Vale position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 117,076 Vale shares in Q2 2022, an estimated $2.34M.
  • Exane Derivatives first reported a position in Vale in Q1 2015 and held it in 19 quarters.
  • Exane Derivatives's Vale position peaked at $11M in Q1 2017.
  • 485 funds tracked by Wall St. Rank held Vale as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.